发明名称 |
Brain, spinal and nerve injury treatment |
摘要 |
A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound. |
申请公布号 |
US9186404(B2) |
申请公布日期 |
2015.11.17 |
申请号 |
US200912475627 |
申请日期 |
2009.06.01 |
申请人 |
EUSTRALIS PHARMACEUTICALS LIMITED |
发明人 |
Nimmo Alan John;Vink Robert |
分类号 |
A61K31/455;A61K31/44;A61K31/496;A61K31/166;A61K45/06;A61K33/06;A61K33/14 |
主分类号 |
A61K31/455 |
代理机构 |
Lathrop & Gage LLP |
代理人 |
Lathrop & Gage LLP ;Trinque Brian C. |
主权项 |
1. A method of treating a mechanical traumatic brain, spinal cord or nerve tissue injury comprising administering to a patient in need of such treatment, a therapeutically effective amount of a pharmaceutical preparation comprising a therapeutically effective amount of a substance P receptor antagonist selected from:
N-(3,5-Bis-trifluoromethyl-benzyl)-N-methyl-6-(4-methyl-piperazin-1-yl)-4-o-tolyl-nicotinamide: N-(3,5-Bis-trifluoromethyl-benzyl)-N-methyl-6-piperazin-1-yl-4-o-tolyl-nicotinamide:or a pharmaceutically acceptable salt thereof. |
地址 |
Pasadena AU |